Redmile Group’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.7M | Sell |
|
|||||
|
2025
Q1 | $29.8M | Sell |
|
|||||
|
2024
Q4 | $50.7M | Sell |
|
|||||
|
2024
Q3 | $57.9M | Sell |
|
|||||
|
2024
Q2 | $63.8M | Sell |
|
|||||
|
2024
Q1 | $68.5M | Buy |
|
|||||
|
2023
Q4 | $13.8M | Sell |
|
|||||
|
2023
Q3 | $15.3M | Sell |
|
|||||
|
2023
Q2 | $42M | Sell |
|
|||||
|
2023
Q1 | $34.5M | Buy |
|
|||||
|
2022
Q4 | $5.93M | Sell |
|
|||||
|
2022
Q3 | $10.7M | Sell |
|
|||||
|
2022
Q2 | $26.3M | Sell |
|
|||||
|
2022
Q1 | $42.6M | Sell |
|
|||||
|
2021
Q4 | $53.9M | Sell |
|
|||||
|
2021
Q3 | $60.6M | Sell |
|
|||||
|
2021
Q2 | $82.8M | Sell |
|
|||||
|
2021
Q1 | $98.8M | Sell |
|
|||||
|
2020
Q4 | $166M | Buy |
|
|||||
|
2020
Q3 | $85.4M | Buy |
|
|||||
|
2020
Q2 | $59.6M | Buy |
|
|||||
|
2020
Q1 | $49.6M | Buy |
|
|||||
|
2019
Q4 | $28.9M | Buy |
|
|||||
|
2019
Q3 | $21.9M | Sell |
|
|||||
|
2019
Q2 | $29.8M | Buy |
|